Ethambutol hydrochloride
Indication
1. Pharmacology This product is a synthetic antibacterial anti-tuberculosis drug. It has strong activity against bacteria in the growth and reproduction period, and has almost no effect on bacteria in the dormant period. It has high antibacterial activity against various types of mycobacteria. There is no cross-resistance between Mycobacterium tuberculosis and other drugs. The mechanism of action of this product has not been fully elucidated. It may be related to inhibiting the metabolism of sensitive bacteria, inhibiting the synthesis of RNA, and interfering with the protein metabolism of Mycobacterium tuberculosis, thereby leading to bacterial death; 2. Toxicology This product can cause cleft palate, brain exposure and spinal deformity in mouse experiments at high doses; it can cause mild cervical deformity in rat experiments; it can cause cyclops, short limbs and cleft palate in rabbit experiments; 3. It can be used in combination with rifampicin or isoniazid to treat various types of active tuberculosis. It can also be used to treat atypical Mycobacterium tuberculosis infection.
Manufacturer
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
-
Founded in:
1962-12-27 -
Address:
No. 48, North Industrial Avenue, Haizhu District, Guangzhou -
Tax NO.:
9144010119046020XE -
Registered Funds:
46.091897 yuan -
Website:
-
Email: